What are the diagnostic criteria and treatment for mixed Hyperosmolar Hyperglycemic State (HHS) and Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Mixed HHS and DKA

Mixed HHS and DKA is diagnosed when a patient simultaneously meets criteria for both conditions: blood glucose >250 mg/dL with ketosis (elevated β-hydroxybutyrate >3.0 mmol/L) AND hyperosmolality (effective osmolality ≥320 mOsm/kg), with variable degrees of acidosis (pH typically 7.0-7.3, bicarbonate 10-18 mEq/L). 1, 2

Core Diagnostic Criteria

The diagnosis requires identifying overlapping features from both conditions simultaneously:

DKA Components Present:

  • Blood glucose >250 mg/dL (though may be lower in euglycemic DKA) 3, 4
  • Venous pH <7.3 (typically 7.0-7.3 in mixed cases) 1
  • Serum bicarbonate <15-18 mEq/L (moderate range in mixed presentations) 1, 3
  • Elevated blood β-hydroxybutyrate (the definitive ketone marker) 3, 4
  • Anion gap >10-12 mEq/L 4

HHS Components Present:

  • Marked hyperglycemia (often >30 mmol/L or ~540 mg/dL) 2
  • Effective plasma osmolality ≥320 mOsm/kg calculated as: 2×[Na+] + [glucose in mg/dL]/18 + [BUN in mg/dL]/2.8 1, 2
  • Severe dehydration with fluid deficits of 100-220 ml/kg 2
  • Altered mental status or obtundation (more prominent than in isolated DKA) 5, 6

Key Distinguishing Feature:

Mixed cases occur in approximately one-third of hyperglycemic emergencies and represent an intermediate state where both ketoacidosis and hyperosmolality are significant. 5, 6

Essential Laboratory Workup

Obtain immediately upon presentation:

  • Blood glucose 1
  • Venous blood gas (arterial not necessary after initial assessment) 1, 3
  • Complete metabolic panel including sodium, potassium, chloride, bicarbonate, BUN, creatinine 1
  • Blood β-hydroxybutyrate (NOT urine ketones or nitroprusside tests) 3, 4
  • Calculated anion gap: [Na+] - ([Cl-] + [HCO3-]) 1, 4
  • Calculated effective osmolality: 2×[Na+] + [glucose]/18 1, 2
  • Corrected sodium: Add 1.6 mEq/L for every 100 mg/dL glucose above 100 mg/dL 1
  • Complete blood count with differential 1
  • Urinalysis 1
  • Serum osmolality (measured) 1
  • Electrocardiogram 1
  • Cultures (blood, urine, throat) if infection suspected 1, 4
  • HbA1c to assess chronicity 1

Critical Ketone Measurement Considerations

Never rely on urine ketones or nitroprusside-based tests for diagnosis or monitoring. 3, 4 These methods only detect acetoacetate and acetone, completely missing β-hydroxybutyrate—the predominant and strongest ketoacid in DKA. 3, 4 During treatment, β-hydroxybutyrate converts to acetoacetate, paradoxically making nitroprusside tests appear worse even as the patient improves. 3, 4

Severity Assessment in Mixed Cases

Classify based on the most severe parameter present:

  • Mild-Moderate: pH 7.00-7.30, bicarbonate 10-18 mEq/L, alert to drowsy 3, 4
  • Severe: pH <7.00, bicarbonate <10 mEq/L, stuporous/comatose, or osmolality >340 mOsm/kg 4, 2

Severe mixed cases require ICU admission with consideration for central venous and intra-arterial pressure monitoring. 4, 5

Common Diagnostic Pitfalls to Avoid

  • Do not dismiss DKA because glucose is <250 mg/dL—euglycemic DKA occurs, especially with SGLT2 inhibitors 3
  • Do not use urine ketones for diagnosis—they miss β-hydroxybutyrate and can be falsely negative early 3, 4
  • Do not assume type 2 diabetes excludes DKA—mixed presentations increasingly occur in type 2 diabetes 3, 5
  • Do not overlook precipitating factors—infection is the most common trigger (70% of cases), followed by newly diagnosed diabetes (17.7%) and medication non-compliance (5.7%) 7

Monitoring During Treatment

Draw blood every 2-4 hours to measure: 1, 3, 4

  • Glucose
  • Electrolytes (sodium, potassium, chloride, bicarbonate)
  • Venous pH (arterial not needed after initial diagnosis)
  • β-hydroxybutyrate
  • Anion gap
  • BUN/creatinine
  • Calculated osmolality

Venous pH adequately tracks acidosis resolution (typically 0.03 units lower than arterial pH) and eliminates need for repeated arterial sticks. 1, 3

Resolution Criteria

Mixed HHS-DKA is resolved when ALL of the following are met: 8, 4, 2

  • Glucose <200 mg/dL
  • Venous pH >7.3
  • Serum bicarbonate ≥18 mEq/L
  • Anion gap ≤12 mEq/L
  • Osmolality <300 mOsm/kg
  • Mental status returned to baseline

Ketonemia takes longer to clear than hyperglycemia—continue monitoring β-hydroxybutyrate even after glucose normalizes. 1, 8

Special Considerations for Mixed Cases

In adults with mixed features, fluid resuscitation may be more aggressive (15-20 ml/kg/h initially) because the risk of cerebral edema is low and consequences of undertreatment include vascular thrombosis and increased mortality. 1, 5 However, in younger patients, avoid rapid correction to minimize cerebral edema risk. 5

Elevated BUN on admission is an independent predictor of mortality in HHS-predominant mixed cases. 7 Mortality in mixed DKA-HHS is approximately 5.9%, intermediate between isolated DKA (<1%) and isolated HHS (21.6%). 7, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Diabetic Ketoacidosis (DKA) in Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.